Trials / Completed
CompletedNCT01654055
International Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments.
International Multicentre Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments: Description and Predictive Factors.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,128 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Morphine is the gold standard for treatment of severe acute pain but it has a number of adverse effects. No study has so far managed to identify the morphine-induced adverse drug reactions. The primary objective of this study is to determine predictive factors of morphine-induced adverse drug reaction when it is used in emergency departments.
Detailed description
We want to study a large cohort of morphine-induced adverse drug reactions patients, the consequences for patients, mainly in terms of severity, and predictive criteria. This will allow us to identify some patients most at risk of morphine-induced adverse drug reactions, and thus to adapt morphine titration and monitoring of these patients. Leading to a better understanding and a better prediction of adverse effects in patients, it is possible that part of the "opiophobia" which persists in emergency services disappear. Finally, it is toward a better security but also a better efficiency in the management of pain patients in emergencies that leads this study. The secondary objectives are: To determine the frequency and severity of adverse events related to morphine. To establish an inventory of morphine use in emergency departments in the different centres studied.
Conditions
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-07-31
- Last updated
- 2017-02-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01654055. Inclusion in this directory is not an endorsement.